Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922778431> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2922778431 endingPage "2158" @default.
- W2922778431 startingPage "2154" @default.
- W2922778431 abstract "Safety surveillance is required for each season’s influenza vaccines to rapidly detect and evaluate potential new safety concerns before the peak period of immunization. Here we report the results of an enhanced passive safety surveillance for a trivalent split-virion inactivated influenza vaccine (IIV3; Vaxigrip®), an intradermal version of this vaccine (IIV3-ID; Intanza® 15 µg), and a recently licensed quadrivalent version (IIV4; VaxigripTetraTM) during the 2017/18 influenza season in the UK and Republic of Ireland. The primary objective was to determine the rates of adverse reactions (ARs) occurring within 7 days following routine vaccination. Between September and November 2017, 979 safety report cards were distributed to vaccinees receiving IIV3-ID, 1005 to those receiving IIV3, and 957 to those receiving IIV4. At least one AR was reported by 28 participants (2.9%) vaccinated with IIV3-ID, 14 participants (1.4%) vaccinated with IIV3, and 20 participants (2.1%) vaccinated with IIV4. The most frequent ARs were injection-site reactions and headache. One participant vaccinated with IIV3-ID reported two suspected serious ARs (dyskinesia and a shock symptom), although these could not be confirmed as vaccine-related. Rates of ARs for IIV3 and IIV3-ID for 2017/18 did not differ from the 2016/17 rates. For IIV4, in its first season since licensure, AR frequencies were similar to those in the Summary of Product Characteristics. In conclusion, no change was found compared to the known or expected AR rates for IIV3, IIV3-ID, or IIV4 during the 2017/18 season." @default.
- W2922778431 created "2019-04-01" @default.
- W2922778431 creator A5012940516 @default.
- W2922778431 creator A5038486523 @default.
- W2922778431 creator A5040219238 @default.
- W2922778431 creator A5047386035 @default.
- W2922778431 creator A5082834209 @default.
- W2922778431 creator A5089227844 @default.
- W2922778431 date "2019-03-27" @default.
- W2922778431 modified "2023-10-18" @default.
- W2922778431 title "Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017/18 season" @default.
- W2922778431 cites W1528690895 @default.
- W2922778431 cites W1669499790 @default.
- W2922778431 cites W1969841948 @default.
- W2922778431 cites W1969886311 @default.
- W2922778431 cites W1993251220 @default.
- W2922778431 cites W2034322687 @default.
- W2922778431 cites W2119384523 @default.
- W2922778431 cites W2248861108 @default.
- W2922778431 cites W2611225176 @default.
- W2922778431 cites W2613574596 @default.
- W2922778431 cites W2760403599 @default.
- W2922778431 cites W2768862194 @default.
- W2922778431 cites W2770822467 @default.
- W2922778431 cites W2811764283 @default.
- W2922778431 cites W2897012863 @default.
- W2922778431 cites W4302076775 @default.
- W2922778431 doi "https://doi.org/10.1080/21645515.2019.1581538" @default.
- W2922778431 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6773376" @default.
- W2922778431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30897026" @default.
- W2922778431 hasPublicationYear "2019" @default.
- W2922778431 type Work @default.
- W2922778431 sameAs 2922778431 @default.
- W2922778431 citedByCount "12" @default.
- W2922778431 countsByYear W29227784312019 @default.
- W2922778431 countsByYear W29227784312020 @default.
- W2922778431 countsByYear W29227784312021 @default.
- W2922778431 countsByYear W29227784312022 @default.
- W2922778431 countsByYear W29227784312023 @default.
- W2922778431 crossrefType "journal-article" @default.
- W2922778431 hasAuthorship W2922778431A5012940516 @default.
- W2922778431 hasAuthorship W2922778431A5038486523 @default.
- W2922778431 hasAuthorship W2922778431A5040219238 @default.
- W2922778431 hasAuthorship W2922778431A5047386035 @default.
- W2922778431 hasAuthorship W2922778431A5082834209 @default.
- W2922778431 hasAuthorship W2922778431A5089227844 @default.
- W2922778431 hasBestOaLocation W29227784311 @default.
- W2922778431 hasConcept C126322002 @default.
- W2922778431 hasConcept C133239900 @default.
- W2922778431 hasConcept C159047783 @default.
- W2922778431 hasConcept C22070199 @default.
- W2922778431 hasConcept C2780689484 @default.
- W2922778431 hasConcept C2911097425 @default.
- W2922778431 hasConcept C71924100 @default.
- W2922778431 hasConceptScore W2922778431C126322002 @default.
- W2922778431 hasConceptScore W2922778431C133239900 @default.
- W2922778431 hasConceptScore W2922778431C159047783 @default.
- W2922778431 hasConceptScore W2922778431C22070199 @default.
- W2922778431 hasConceptScore W2922778431C2780689484 @default.
- W2922778431 hasConceptScore W2922778431C2911097425 @default.
- W2922778431 hasConceptScore W2922778431C71924100 @default.
- W2922778431 hasIssue "9" @default.
- W2922778431 hasLocation W29227784311 @default.
- W2922778431 hasLocation W29227784312 @default.
- W2922778431 hasLocation W29227784313 @default.
- W2922778431 hasLocation W29227784314 @default.
- W2922778431 hasOpenAccess W2922778431 @default.
- W2922778431 hasPrimaryLocation W29227784311 @default.
- W2922778431 hasRelatedWork W1933553852 @default.
- W2922778431 hasRelatedWork W2040726440 @default.
- W2922778431 hasRelatedWork W2605671364 @default.
- W2922778431 hasRelatedWork W2925588001 @default.
- W2922778431 hasRelatedWork W2946153279 @default.
- W2922778431 hasRelatedWork W4229375071 @default.
- W2922778431 hasRelatedWork W4245649977 @default.
- W2922778431 hasRelatedWork W4300477966 @default.
- W2922778431 hasRelatedWork W4301207092 @default.
- W2922778431 hasRelatedWork W4301671533 @default.
- W2922778431 hasVolume "15" @default.
- W2922778431 isParatext "false" @default.
- W2922778431 isRetracted "false" @default.
- W2922778431 magId "2922778431" @default.
- W2922778431 workType "article" @default.